ArticleNPJ breast cancer2017

Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo.

Jason J Zoeller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.